documents: FDA-2012-D-0307-0013
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-D-0307-0013 | FDA | FDA-2012-D-0307 | Reference 01 - Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by blood and blood products re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability | Supporting & Related Material | Background Material | 2017-12-22T05:00:00Z | 2017 | 12 | 2017-12-22T16:24:28Z | 0 | 0 | 0900006482d5882c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref